Physician profile
David Walsh
NPI 1427379270
$967.17
in general payments reported to CMS, 2019-2025
8 companies · $94.23 in 2025
The $94.23 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $126 · 2021: $128 · 2022: $140 · 2023: $187 · 2024: $158 · 2025: $94.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.71 | 2021-2024 | Teflaro, Dalvance, Avycaz |
| Pfizer INC. | $230.43 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $179.45 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $96.97 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $89.11 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $50.14 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $35.77 | 2023-2024 | Inpefa |
| Microvention, INC. | $22.59 | 2023 | Sofia 6f-131cm Str |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.